Short Interest in Addex Therapeutics Ltd (OTCMKTS:ADDXF) Drops By 58.3%

Addex Therapeutics Ltd (OTCMKTS:ADDXFGet Rating) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 28,800 shares, a decrease of 58.3% from the April 30th total of 69,100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Shares of OTCMKTS:ADDXF opened at $0.99 on Friday. Addex Therapeutics has a 1 year low of $0.99 and a 1 year high of $0.99. The firm has a fifty day moving average price of $0.99 and a 200 day moving average price of $1.23.

About Addex Therapeutics (Get Rating)

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors.

Further Reading

Receive News & Ratings for Addex Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addex Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.